
|Articles|October 25, 2021
Daily Medication Pearl: Zioptan (Tafluprost Ophthalmic Solution) for Glaucoma, Ocular Hypertension
Author(s)Saro Arakelians, PharmD
Tafluprost acid, a prostaglandin analog, is a selective FP prostanoid receptor agonist that is believed to reduce intraocular pressure by increasing uveoscleral outflow.
Advertisement
Medication Pearl of the Day: Zioptan (Tafluprost Ophthalmic Solution)
Indication: Zioptan is a prostaglandin analog indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Insight:
- Dosing: One drop in the affected eye(s) once daily in the evening.
- Dosage form: Ophthalmic solution containing tafluprost 0.015 mg/mL.
- Adverse events (AEs): Most common ocular AE is conjunctival hyperemia.
- Mechanism of action:Tafluprost acid, a prostaglandin analog, is a selective FP prostanoid receptor agonist that is believed to reduce intraocular pressure by increasing uveoscleral outflow. The exact mechanism of action is unknown at this time.
- Manufacturer: AKORN
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
IRAKLIA Trial Shows Body Weight Doesn’t Alter Outcomes With On-Body Injector Isatuximab
2
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
3
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5

















































































































































































































